◀ Back to PTBP1

HDAC1 — PTBP1

Text-mined interactions from Literome

Nencioni et al., Clin Cancer Res 2007 : Here, we have evaluated the effects of two HDAC inhibitors currently in clinical use, sodium valproate and MS-275, on human monocyte derived DCs
Kuriyama et al., Neuropharmacology 2013 : The effectiveness of D-cycloserine (DCS) , an N-methyl-D-aspartate glutamate receptor partial agonist, and valproic acid ( VPA ), a histone deacetylase inhibitor , in facilitating the extinction of fear conditioned memory has been explored in humans and animals
Ye et al., J Cell Sci 2013 : HDAC5-deficient mice have reduced cardiac PTB protein abundance, and HDAC inhibition in myocytes causes a reduction in endogenous expression of cellular FLICE-like inhibitory protein ( cFLIP ) and caspase dependent cleavage of PTB